Accrual Pharma Pack Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.20 M
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 12.04 Cr
- Revenue Growth 2113.21%
- Profit Growth -380.94%
- Ebitda 2281.87%
- Total Assets 1.81%
About Accrual Pharma Pack Llp
Accrual Pharma Pack Llp (APPL) is 9 Year, 1 Month old Limited Liability Partnership 31 December 2015. Its registered office is in Mumbai, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2021 (FY 2020-2021). It's Total Obligation of Contribution is Rs 0.20 M as per MCA.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAF-4130
- Incorporation Date
31 Dec 2015
- Date of Accounts and Solvency Statement
31 Mar 2021
- ROC Code
Roc-Mumbai
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Accrual Pharma Pack Llp?
Designated Partners (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kushal Sanghvi  | Designated Partner | 31-Dec-2015 | Current |
| Aneri Sanghvi | Designated Partner | 31-Dec-2015 | Current |
Financial Performance of Accrual Pharma Pack Llp.
Accrual Pharma Pack Llp, for the financial year ended 2019, experienced significant growth in revenue, with a 2113.21% increase. The company also saw a substantial fall in profitability, with a 380.94% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accrual Pharma Pack Llp?
Unlock access to Accrual Pharma Pack Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Prominence Electric (India) Private LimitedKushal Sanghvi and Aneri Sanghvi are mutual person
Charges (Loans)
₹120.41 M
₹0
Charges Breakdown by Lending Institutions
- Svc Co Operative Bank Limited : 6.17 Cr
- Svc Co-Operative Bank Limited : 5.35 Cr
- Svc Cooperative Bank Limited : 0.36 Cr
- Svc Co-Operative Bank Ltd : 0.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 2023 | Svc Cooperative Bank Limited | ₹3.60 M | Open |
| 05 Jul 2023 | Svc Co Operative Bank Limited | ₹2.74 M | Open |
| 09 May 2023 | Svc Co Operative Bank Limited | ₹6.58 M | Open |
| 11 Oct 2021 | Svc Co-Operative Bank Limited | ₹3.77 M | Open |
| 26 Mar 2021 | Svc Co-Operative Bank Limited | ₹5.49 M | Open |
How Many Employees Work at Accrual Pharma Pack Llp?
Unlock and access historical data on people associated with Accrual Pharma Pack Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accrual Pharma Pack Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accrual Pharma Pack Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.